Clinical trials
Allergy clinical trials
Below are recruiting allergy clinical trials, each written for real people, not researchers. We’re tracking 318 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05331170RecruitingPhase 2
Re-training the nose to change how allergies behave
This Phase 2 study tests a “viral” treatment meant to reprogram the lining of your nose to reduce allergy-like immune responses. It is testing whether this approach is safe and can help people with cat allergy (with or without asthma) or compare against healthy people.
Galveston, TexasAges 18–60 - NCT06328504Recruiting
Cashew allergy treatment with cashew protein
This trial tests whether giving very small amounts of cashew protein (like a food immunotherapy) can help children and teens with cashew allergy become less allergic. If it works, it might lower the risk of severe reactions.
Warsaw, Masovian VoivodeshipAges 4–17 - NCT06814223RecruitingPhase 4
Can antibiotics prevent catheter infections in dialysis patients?
This study tests if giving antibiotics before placing a dialysis catheter can prevent infections. It may help people with heart conditions or those who need a catheter in the leg.
Nahariya, IsraelAges 18 years+ - NCT07419243RecruitingPhase 1/Phase 2
Tolerance in milk and egg allergy in children
This study watches how milk and egg allergies change naturally over time or after oral immunotherapy (OIT) in children. It helps researchers understand how the immune system adapts, aiming to improve treatment for food allergies.
Madrid, MadridAges 4–17 - NCT07416201Recruiting
Study of Immune System Aging in Down Syndrome
This study is looking at how the immune system changes over time in people with Down syndrome, and how it may be affected by removal of the thymus gland. The goal is to understand why people with Down syndrome may age faster or have different immune health.
Bethesda, MarylandAges 1–120 - NCT07402200Recruiting
Indoor air pollutants and child health study
This study looks at how indoor air pollution affects children's health. It compares children with allergies or asthma to those without, to see if air quality plays a role.
MontpellierAges 8–12 - NCT07404956Recruiting
Comparing surgical and N95 masks for operating room nurses
This study checks how wearing a surgical mask or an N95 mask affects the air quality during surgery (called surgical smoke). It is for operating room nurses who work with surgical smoke regularly.
Bartın, BartınAges 18 years+ - NCT07390955RecruitingPhase 1
Safety study of three anti-HIV antibodies in healthy adults
This study is testing three experimental antibodies (ePGT121v1-LS, PGDM1400LS, and VRC07-523LS) that may help prevent HIV. It’s looking at their safety and how long they stay in the body. Healthy volunteers without HIV can join.
Birmingham, AlabamaAges 18–55 - NCT07390474RecruitingPhase 1
HIV vaccine safety and immune response study for healthy adults
This study tests two experimental mRNA-based HIV vaccines to see if they are safe and create an immune response. It is for healthy adults aged 18 to 55 who do not have HIV.
Atlanta, GeorgiaAges 18–55 - NCT07342491RecruitingPhase 1
Testing dasatinib to shrink HIV reservoir
This trial tests whether the drug dasatinib can reduce the hidden HIV reservoir in people who have had their virus well-controlled on HIV medications for a long time. It may help move toward a cure by targeting the cells where HIV hides.
Chicago, IllinoisAges 18 years+ - NCT07321522Recruiting
Early feeding of allergenic foods in infants
This study tests whether introducing common allergenic foods early and continuing them for six months can help prevent food allergies in infants. It is for babies who have not yet started these foods.
Stanford, CaliforniaAges 4 months–11 months - NCT07288827Recruiting
Study of airway sensitivity in primary ciliary dyskinesia
This study looks at how the airways in people with primary ciliary dyskinesia (PCD) react to certain triggers. It aims to understand if these airways are more sensitive, which could help improve treatment for breathing problems.
Indianapolis, IndianaAges 6 years+ - NCT07271381Recruiting
Testing how allergens and everyday toxins affect your body
This study looks at how common allergens and everyday toxins from things like cleaning products affect your skin, gut, and airways. It may help find ways to prevent or manage allergies and related health issues.
Bethesda, MarylandAges 18–80 - NCT07228325Enrolling by invitationPhase 1/Phase 2
Comparing a new epinephrine injector to EpiPen in adults with allergies
This study tests a new epinephrine auto-injector (FMXIN002) compared to the standard EpiPen in people with a history of hay fever or seasonal allergies. The goal is to see if the new device works just as well and is safe in a controlled clinic setting.
MississaugaAges 18–55 - NCT07216794RecruitingPhase 2
Alendronate trial to reduce hidden HIV
This study tests if alendronate, a bone-strengthening medicine, can shrink the reservoir of HIV that stays in your body even when on treatment. You must have well-controlled HIV on antiretroviral therapy for at least one year but no more than ten years, and meet specific health requirements.
San Francisco, CaliforniaAges 18–65 - NCT07212530Recruiting
EmoTIChealth: A game to boost teen health
This trial tests a serious video game designed to help teenagers learn skills for better health. It's for 12- to 16-year-olds who speak Spanish and have internet access.
Valencia, ValenciaAges 12–16 - NCT06138431Recruiting
Group therapy for parents of children with food allergies
This study tests a group therapy program to help parents manage anxiety or depression related to their child's serious food allergy. You'll attend 6 weekly group sessions and fill out questionnaires online to see if the program helps you feel better.
Kansas City, MissouriAges 1.5 years–17 years - NCT06916819Recruiting
Food allergy testing: at home or in clinic?
This study compares doing a food challenge at home versus in a medical clinic for people who think they might be allergic to a food. If you are over 18 and your skin test to that food is negative, you may be able to join.
Melbourne, VictoriaAges 18 years+ - NCT07202598RecruitingPhase 2
Testing emapalumab for gut inflammation in APECED
This trial tests a drug called emapalumab to treat chronic gut inflammation (enteritis) in people with APECED, a rare immune disorder. It aims to see if the drug can help when other treatments haven't worked.
Bethesda, MarylandAges 2–75 - NCT04163562RecruitingPhase 1/Phase 2
Oral peanut treatment trial for people with peanut allergy
This trial tests an oral (by mouth) immune treatment for people with confirmed peanut allergy. It aims to see whether your immune system can become less reactive to peanuts over time, while keeping you safe during testing with careful emergency planning.
Pamplona, NavarreAges 12–65 - NCT07169318RecruitingPhase 1
Safety study of VNT-101 in healthy adults
This first-in-human study tests the safety of a new medicine called VNT-101. Healthy adults aged 18 to 59 who do not smoke and have no major health problems may be able to join. The goal is to see how the body handles the drug and if it is safe.
Overland Park, KansasAges 18–59 - NCT05532566Recruiting
Tested oak tree allergy extracts for people with inhalant allergy
This trial studies how well standardized oak (Quercus ilex and Quercus robur) allergen extracts match your specific allergy. It may help refine allergy testing and treatment planning for people with oak-triggered rhinitis, eye symptoms, and/or asthma.
MadridAges 18–64 - NCT04891237RecruitingPhase 3
Grass and olive allergy vaccine trial for teens to older adults
This Phase 3 trial tests whether an allergy treatment can reduce symptoms caused by grass and olive pollen. It also checks safety, especially for breathing and allergic reactions, in people with confirmed grass/olive allergy.
Tarancón, CuencaAges 12–65 - NCT07117669RecruitingPhase 1/Phase 2
Testing a new peanut allergy treatment (ENP-501)
This trial tests a new peanut allergy treatment called ENP-501. It aims to see if the medicine can safely help people with peanut allergy become less sensitive to peanuts.
Aurora, ColoradoAges 14–50
Hear when a new Allergy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for allergy?
- Yes. Clin2 currently lists 318 recruiting allergy studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a allergy trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a allergy trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.